nygazet.com logo
Ozempic does not slow Alzheimer’s, study finds
business

Ozempic does not slow Alzheimer’s, study finds

1 min read

Novo Nordisk’s shares fell 6% on the news.

Ozempic does not slow Alzheimer’s progression, its manufacturer Novo Nordisk said following a two-year study. The popular drug reduces body weight by on average around 15% in obese patients, and early data suggested it may also slow the progress of s... [257 chars]

Read Original Article

Source: https-//www.semafor.com

Visit Source

Share this article